Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 27;13(7):e16667.
doi: 10.7759/cureus.16667. eCollection 2021 Jul.

Cutaneous Manifestations of COVID-19: An Experience From Oman

Aisha Al Ali  1 , Safiya Al-Shidhani  1 , Fatma Al-Balushi  1 , Mohammed Alhinai  2 , Abdul Rahman Al-Azri  3 , Sultan Al Lawati Al Lawati  4 , Farah Al Ghailani  1 , Reham Al Riyami  1
Affiliations

Cutaneous Manifestations of COVID-19: An Experience From Oman

Aisha Al Ali et al. Cureus. .

Abstract

Objectives: To identify the cutaneous manifestations in COVID-19 disease in Oman.

Methods: The study was conducted in two phases with initial cross-sectional data collection with subsequent telemedical investigations of late skin manifestations including confirmed COVID-19 patients evaluated at Al-Nahdha Hospital and local health centers in Muscat from March 22 to June 2, 2020.

Results: The total number of patients included in the study was 374. Cutaneous manifestations were observed in 1.87% (n=7) of patients at presentation with an additional 1.6% (n=5) on follow-up. The types of skin reactions included maculopapular rash (n=6), urticaria (n=2), transient pruritic erythema (n=1), pruritic palmoplantar erythema (n=1), pustular eruption (n=1) and flare-up of atopic dermatitis (n=1).

Conclusions: The low percentage of skin lesions is not contradicting previous data and it might just reflect under-reporting of skin rash in the context of the presence of more severe symptoms in our sample population. Skin lesions can still be utilized to treat patients as suspected cases until proven otherwise as it can be a silent clue in asymptomatic patients.

Keywords: corona virus; covid-19; cutaneous manifestations; sars-cov-2; skin manifestations.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Symptoms of COVID-19 in Muscat Region
Figure 2
Figure 2. maculo-papular rash
Figure 3
Figure 3. transient pruritic erythema
Figure 4
Figure 4. Urticarial Eruption
Figure 5
Figure 5. pustular eruption with erythematous background
See this image and copyright information in PMC

References

    1. The outbreak of COVID-19: an overview. Wu YC, Chen CS, Chan YJ. J Chin Med Assoc. 2020;83:217–220. - PMC - PubMed
    1. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. Wang D, Hu B, Hu C, et al. 2020;17:1061–1069. - PMC - PubMed
    1. Cutaneous manifestations in COVID-19: a first perspective. Recalcati S. J Eur Acad Dermatol Venereol. 2020;34:0–3. - PubMed
    1. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Galván Casas C, Català A, Carretero Hernández G, et al. Br J Dermatol. 2020;183:71–77. - PMC - PubMed
    1. Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhang Y, Cao W, Xiao M, et al. Zhonghua Xue Ye Xue Za Zhi. 2020;41:302–307. - PMC - PubMed

LinkOut - more resources